Study Highlights Positives and Negatives of Medical Marijuana
This study highlights medical cannabis clinical evidence showing therapeutic value for chronic pain and chemotherapy-induced nausea. It also discusses the risks and limitations of current research. Understanding these factors helps guide informed…
Alabama Medical Cannabis Sales Gear for Spring 2026 Launch
The Alabama medical cannabis program moves forward with retail sales expected in spring 2026. Clinicians must prepare to evaluate and recommend medical cannabis products effectively. This program marks a significant change in patient access within the…
West Virginia House Passes Bill To Allocate Medical Marijuana Revenue, With Some …
West Virginia's legislature has passed a bill for medical marijuana revenue allocation, directing funds to university cannabis research. This allocation aims to generate clinical evidence to guide safe prescribing practices. The focus on medical…
‘Green Lab’ Aids Oregon Officers in Cannabis-Impaired Driving Recognition
Cannabis-impaired driving recognition is improving through Oregon's innovative 'green lab' training for law enforcement. This standardized approach helps officers identify impairment more reliably. Clinicians should incorporate this knowledge when…
Cannabis Compounds CBD and CBG Slash Liver Fat and Restore Metabolic Health
Metabolic-associated fatty liver disease is a growing concern worldwide. Research suggests that cannabis compounds CBD and CBG may reduce liver fat and improve metabolic markers. These findings highlight potential adjunctive therapies for metabolic…
Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and … – PubMed
Cannabinoid oral mucosal delivery offers a promising approach to improve bioavailability and dosing consistency. This method bypasses hepatic first-pass metabolism, enhancing therapeutic efficacy. Research on oral mucosal delivery systems addresses…
Regulatory Digest: DEA Enforcement & Controlled Substances March 2026
This regulatory digest covers DEA enforcement controlled substances updates relevant to cannabis and synthetic cannabinoid importation. The March 2026 notices highlight scheduling changes and import restrictions. Clinicians should stay informed about…
Adolescent Cannabis Psychiatric Outcomes: New 2026 Insights
Recent research highlights adolescent cannabis psychiatric outcomes, emphasizing risks linked to teen cannabis use. The developing brain is vulnerable to cannabis effects, increasing psychiatric disorder risks. This 2026 digest presents new insights into…
WAFB – Louisiana Lawmaker Files Bill to Legalize Recreational Marijuana
A louisiana recreational marijuana legalization bill has been introduced by a state legislator, proposing licensed dispensary sales. This bill marks a significant shift in louisiana cannabis policy. The legislation could expand legal access beyond…
Study Highlights Pros and Cons of Medical Marijuana in Tennessee
This study highlights medical cannabis benefits and risks as Tennessee faces uncertain policy changes. Clinicians must navigate evolving evidence to counsel patients effectively. Federal rescheduling may soon improve research and prescribing clarity.
